Related Experiment Videos

Relationship between depression and non-adherence to anticoagulant therapy after valve replacement

A M El-Gatit1, A S El-Gatit, M Haw

  • 1Annour Clinic, Red Crescent, Misurata, Libyan Arab Jamahiriya.

Insights

Depression significantly impacts patient adherence to warfarin therapy and clinic visits after mechanical valve replacement. Managing depression is crucial for improving anticoagulant treatment compliance in developing countries.

Area of Science:

  • Cardiology
  • Psychiatry
  • Pharmacology

Background:

  • Anticoagulant therapy management post-mechanical valve replacement is challenging in developing nations due to poor patient adherence.
  • Warfarin is a common anticoagulant requiring strict adherence for efficacy and safety.

Purpose of the Study:

  • To evaluate the effect of depression on adherence to warfarin therapy and clinic appointments in patients with mechanical heart valves.
  • To explore the relationship between depression, anxiety, social support, and adherence.

Main Methods:

  • Sixty-two patients receiving mechanical heart prostheses and prescribed daily warfarin were studied.
  • Depression was assessed using the Center for Epidemiological Studies Depression Scale.
  • Adherence to medication and clinic visits was monitored over a 3-week interval.

Main Results:

  • Twenty-two out of 62 patients were identified as depressed.
  • Non-depressed patients demonstrated significantly better adherence to warfarin and clinic visits compared to depressed patients.
  • Adherence showed a negative correlation with depression scores.

Conclusions:

  • Depression is a significant barrier to anticoagulant therapy adherence in patients with mechanical heart valves.
  • Interventions addressing depression, anxiety, and social support may improve treatment outcomes in this population.
  • Optimizing anticoagulant management requires a holistic approach considering psychological factors.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...